No Sign Latest COVID Variant Leads to Worse Symptoms

Medically reviewed by Drugs.com.

By Robin Foster HealthDay Reporter

WEDNESDAY, Jan. 24, 2024 -- JN.1, the COVID variant sweeping the country this winter, is not prompting more severe disease than earlier variants did, early U.S. government data suggests.

While it does not appear to be more deadly than its predecessors, the JN.1 variant has surged in recent months and now accounts for 85.7% of all U.S. cases, according to the U.S. Centers for Disease Control and Prevention.

The agency is waiting for additional data to craft a more detailed analysis of JN.1's impact this season, Dr. Eduardo Azziz-Baumgartner, chief of the global influenza branch in CDC’s Influenza Division, said during a webinar with testing laboratories hosted by the agency this week, CBS News reported.

Asked if JN.1's symptoms seemed to be more severe than earlier COVID waves, he said, "There are early signals that that may not be the case," based on electronic medical records and other data.

He added that a virus' effect on an individual can vary widely, however. "It could be very severe. People could die from a virus that, to the general population, may be milder."

The CDC plans to release more details about JN.1's severity "during the next couple weeks" as more data is gathered on the variant, Azziz-Baumgartner added.

Still, the CDC and other federal health agencies have not moved to deem JN.1 a variant of interest, even though the World Health Organization did just that last month.

But the WHO also said last Friday that there were "currently no reported laboratory or epidemiological reports" linking JN.1 to increased disease severity.

The CDC's experts also reported earlier this month that hospitalization rates appeared to be lower than they were last season.

Azziz-Baumgartner cautioned that data lags could be muddying the picture, and officials have also been watching for any renewed spike in the spread of the flu.

Some regions have also been reporting a strain on hospitals, especially in New England, he added.

Just last week, Massachusetts General Hospital warned it was taking steps to address an "unprecedented overcrowding" crisis, along with other hospitals in the state.

Sources

  • CBS News
  • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords